In the AD-DLB vs AD alone comparison, the upregulation of NIPSNAP2, MT-ND2, STOM, and ATP6V0C indicates compensatory mechanisms to deal with metabolic dysfunctions and increased demands of protein degradation in AD-DLB. This evidence concerns the gene STOM and Alzheimer disease.